Direct-To-Consumer Genetic Testing Market Size, Top Players, and Forecast by 2031
Direct-To-Consumer Genetic Testing Market: Size and Share
-
CAGR (2022 - 2030)19.6% -
Market Size 2022
US$ 1,715.84 Million -
Market Size 2030
US$ 7,191.68 Million
Market Dynamics
- Increasing incidence of genetic disorders
- Rising public awareness of direct-to-consumer genetic testing
- New Product Launches by Companies is likely to Create Opportunities in Future Years for the overall Market
Market Segmentation
- Nutrigenomics Testing
- Predictive Testing
- Carrier Testing
- Whole Genome Sequencing
- Single Nucleotide Polymorphism Chips
- Targeted Analysis
- Online
- Offline
Direct-To-Consumer Genetic Testing Market Players Density: Understanding Its Impact on Business Dynamics
The Direct-To-Consumer Genetic Testing Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Direct-To-Consumer Genetic Testing Market are:
- 23andMe, Inc.,
- Full Genome Corporation Inc.,
- Ancestry,
- Counsyl,
- Gene by Gene,
- Easy DNA,
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Direct-To-Consumer Genetic Testing Market top key players overview